内源性阿片类系统以性别依赖的方式调节条件可卡因奖励
Kanako Matsumura1,2, Amélia Nicot3, In Bae Choi4
1Institute for Neuroscience, The University of Texas at Austin, Austin, Texas, USA.
Addiction biology
|September 27, 2023
概括
在寻找可卡因的行为中,状脑不是必不可少的. 然而,阿片类药物对抗剂阻断了雌性小鼠的可卡因偏好表达和灭绝,这表明性别特定的阿片类药物参与了可卡因使用障碍.
科学领域:
- 神经科学是一个神经科学.
- 行为药理学行为药理学
- 成研究 研究成研究
背景情况:
- 寻找可卡因受到预测线索和背景的影响.
- 由阿片类调节的状回路编码有条件的行为.
- 之前的研究将条状脑素与可卡因条件的位置偏好 (CPP) 获得和阿片类抗体与CPP表达联系起来.
研究的目的:
- 调查状脑是否对于可卡因CPP的获取和灭绝是必要的.
- 检查条状脑在可卡因诱导行为的表达和灭绝中的作用.
- 探索阿片类受体对抗剂对可卡因CPP的影响的性别差异.
主要方法:
- 产生的小鼠有针对性地从多巴胺D2受体中删除恩基法林,表达中等棘手神经元.
- 利用可卡因条件的位置偏好 (CPP) 范式来评估行为反应.
- 使用纳洛 (阿片类受体对抗剂) 来评估其对CPP表达和灭绝的影响.
主要成果:
- 较低的条状脑素水平并没有影响可卡因CPP的获取.
- 纳洛在雌性小鼠中阻止了可卡因CPP的表达,不论其基因型如何.
- 无论基因型如何,雌性都比雄性更快地消灭偏好,这种效应在灭绝训练期间被纳洛阻止.
- 这些发现表明,条状脑不是可卡因CPP获得,表达或灭绝的关键.
结论:
- 对于可卡因的获得,表达或灭绝,状脑是不必要的.
- 雌性中可卡因偏好表达和灭绝是由除条性脑神经外的其他阿片类介导的.
- 对阿片类药物抗剂的反应中的性别差异凸显了在可卡因使用障碍治疗策略中考虑性别的重要性.
相关概念视频
Opioid Receptors: Overview
984
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
984
Drug Abuse and Addiction: Pharmacological Phenomena
501
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
501
Analgesia and Pain Management
649
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
649
Neurochemical Transmission: Sites of Drug Action
2.5K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.5K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
224
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
224
Opioid Analgesics: Synthetic and Semisynthetic Opioids
326
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
326


